Statements in which the resource exists as a subject.
PredicateObject
rdf:type
skos:definition
"A substituted aniline that is benzene-1,2,4-triamine bearing ethoxycarbonyl and 4-fluorobenzyl substituents at positions N-1 and N-4 respectively. An anticonvulsant used to treat seizures associated with epilepsy in adults." []
skos:inScheme
skos:prefLabel
ezogabine
skos:notation
ChemIDplus:150812-12-7 "CAS Registry Number", CiteXplore:22991134 "PubMed citation", KEGG COMPOUND:150812-12-7 "CAS Registry Number", KEGG COMPOUND:C13826 "KEGG COMPOUND", KEGG DRUG:D09569 "KEGG DRUG", Patent:US2002015730 "Patent", Patent:US2002111379 "Patent", Patent:US2002183395 "Patent", Patent:US2012053238 "Patent", Patent:US5384330 "Patent", Patent:US6348486 "Patent", Patent:WO2007090409 "Patent", Patent:WO2011012659 "Patent", Reaxys:8072099 "Reaxys Registry Number", Wikipedia:Ezogabine "Wikipedia"
skos:broader
skos:relatedSynonym
Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate, D-23129, N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester, Potiga, N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester, retigabine, ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate, C16H18FN3O2, CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N, InChI=1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21), InChIKey=PCOBBVZJEWWZFR-UHFFFAOYSA-N